- TraderTV Research
- Posts
- Trader TV Watchlist - November 10, 2025
Trader TV Watchlist - November 10, 2025
Monday November 10, 2025
Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.
TraderTV.LIVE™ features a daily live trading broadcast, professional education and an active community of more than 450,000 subscribers. Join us on YouTube every weekday from 8:30am to 4:30pm EST for the first and only professional trading show on YouTube Live!
Premarket Trading:
Trading Higher ($): NVDA, B, RUM
Trading Lower ($): MTSR, MNDY, OSCR
Earnings Today:
Premarket: MNDY, B, CART
Post-market: CRWV, BBAI, RGTI
In The News
NVIDIA Corp (NVDA)
+3.11%
CEO Jensen Huang said the company is seeing “very strong demand” for its Blackwell chips, driving increased wafer orders from TSMC. Speaking at a TSMC event on Saturday, Huang highlighted Nvidia’s broader chip ecosystem—including GPUs, CPUs, and networking components. TSMC Chairman C.C. Wei confirmed Nvidia’s large wafer requests but did not provide any specifics.
Tesla Inc (TSLA)
+2.23%
On watch after data from the China Passenger Car Association showed that the company’s China sales plunged 35.8% year-over-year in October to 26,006 vehicles, the lowest in three years. Despite the slump, exports of China-made vehicles hit a two-year high of 35,491 units. Separately, Cybertruck program head Siddhant Awasthi announced his departure from Tesla after eight years at the company.
Robinhood Markets Inc (HOOD)
+3.80%
Trading sharply higher premarket after the Financial Times reported that Robinhood is developing a tradeable fund through Robinhood Ventures that would let retail investors gain exposure to select private AI startups. The closed-end fund, which may use leverage, would invest in a small group of top private AI firms but could involve locked-up capital and total loss risk.
Metsera Inc (MTSR)
-14.94%
Gapping down after Pfizer clinched a $10 billion deal to acquire the obesity drug developer, outbidding Novo Nordisk after a heated contest. Metsera accepted Pfizer’s revised $86.25-per-share offer, citing antitrust risks in Novo’s proposal. The deal includes cash and contingent value rights worth up to $20.65 per share.
monday.com Ltd (MNDY)
-16.62%
Gapping down after its Q3 2025 earnings report. Adjusted earnings of $1.16 per share beat estimates of $0.88, while sales of $316.855 million beat estimates of $312.306 million. The company guided Q4 sales between $328 million and $330 million, below estimates of $333.681 million. Monday narrowed its FY25 sales guide to $1.226 billion-$1.228 billion, compared to estimates of $1.226 billion.
Barrick Mining Corp (B)
+4.53%
Trading sharply higher premarket following its Q3 2025 earnings report. Adjusted earnings of $0.58 per share narrowly beat estimates of $0.57, while sales of $4.148 billion fell short of the expected $4.16 billion. The company increased its share buyback program by $500 million, announced a 25% increase to its base dividend, and declared an enhanced dividend for Q3 2025.
Health Insurance Companies
-4.14%
Trading sharply lower as a group after US President Donald Trump shared a pair of Truth Social posts about the industry over the weekend. In the first of these posts, Trump called for federal healthcare funds to go directly to individuals instead of “money-sucking” insurance companies; in the second, Trump advocated for paying “the people, not the insurance companies!”. Trump’s posts came amid ongoing Senate negotiations to end the prolonged government shutdown tied to Obamacare subsidies.
CNC, OSCR, UNH, MOH, CI, HUM
American Airlines Inc (AAL)
+1.83%
Trading marginally higher premarket after the US Senate voted to advance a funding measure on Sunday evening, marking progress towards the resolution of the US government shutdown. American and other major US airlines faced their worst day of disruptions since the government shutdown began, with over 2,800 flight cancellations and 10,200 delays on Sunday due to air traffic control staffing shortages. Transportation Secretary Sean Duffy warned that conditions will deteriorate further should the shutdown continue, with air travel potentially reduced to a “trickle” ahead of Thanksgiving.
Rivian Automotive Inc (RIVN)
+2.10%
The company granted CEO RJ Scaringe a new pay package worth up to $4.6 billion over ten years, modeled after Elon Musk’s Tesla compensation plan and tied to ambitious profit and stock price goals. The automaker said the deal aims to retain Scaringe and drive growth as Rivian prepares to launch its lower-cost R2 SUV next year to compete with Tesla’s Model Y.
Maplebear Inc (Instacart) (CART)
+7.78%
Trading sharply higher premarket following its Q3 2025 earnings report, with revenue of $939 million beating estimates of $933 million and marking a 10% year-over-year improvement. The company posted adjusted EBITDA of $278 million for the quarter, up 22% year-over-year and exceeding analyst estimates of $264.5 million. Instacart announced a $1.5 billion increase to its share buyback program.
Rumble Inc (RUM)
+16.47%
Gapping up after announcing a deal to acquire German AI cloud firm Northern Data in an all-stock deal valued at about $767 million. The company is offering 2.0281 Rumble shares for each Northern Data share, a 12.99% discount to Northern Data’s last close. Upon completion in mid-2026, Northern Data shareholders will own 30.4% of Rumble.
Novo Nordisk A/S (NVO)
+1.40%
The company partnered with India’s Emcure Pharmaceuticals to exclusively distribute and market its weight-loss drug under the new brand Poviztra, a 2.4 mg semaglutide injection separate from Wegovy. This partnership marks an expansion of Novo’s presence in India following Wegovy’s June launch in the country.
Plug Power Inc (PLUG)
+9.81%
Gapping up after signing a non-binding letter of intent to monetize electricity rights in New York and another location while partnering with a US data center developer. The company expects to generate over $275 million through asset monetization, release of restricted cash, and reduced maintenance costs, supporting liquidity improvement.
Galecto Inc (GLTO)
+254.55%
Gapping up after announcing its acquisition of Damora Therapeutics, supported by an oversubscribed $285 million private investment. The combined company, which will include Damora’s anti-mutant calreticulin therapies led by DMR-001, expects a financial runway into 2029 and aims to report Phase 1 proof-of-concept data for DMR-001 in 2027. Galecto has a market capitalization of $6.57 million and a float of 1.29 million shares.


